The main purpose of this legislation is to improve the ability of outsourcing facilities to help prevent and manage drug shortages. It aims to do this by allowing these facilities to continue supplying drugs to the market for a short period after a drug has been officially recognized as being in shortage. The key provisions of the legislation include changes to existing rules that govern outsourcing facilities. Specifically, it modifies the timeframe in which these facilities can compound and distribute drugs that are in shortage.